This case report throws some light on the way in which the body handles an infected onlay mesh following groin hernia repair. It describes the case of a 73-year-old man who developed this rare complication and demonstrates the mechanism by which this complication occurred.

Papillary lesions of breast represent a range of lesions. Intraductal papilloma and its association with nipple discharge are well known. However, multiple papillomatosis has quite distinct characteristics and decision making can be somewhat challenging. We report a case of multiple papillomatosis in association with ductal carcinoma in situ (DCIS). Patient opted for ipsilateral mastectomy and prophylactic mastectomy of contralateral breast. Her decision of having prophylactic mastectomy was vindicated by presence of incidental DCIS in the contralateral breast. To our knowledge, this is the first reported case of multiple papillomatosis with DCIS of breast, along with incidental synchronous papillomatosis of contralateral breast with DCIS. The case illustrates few distinct features of multiple papillomatosis of breast and exemplifies how a patient's choice is so paramount in decision making process. Patients should be fully informed of the treatment options of the condition, and their wishes should be fully taken into account while making the final decision.

No abstract

Objectives: An association between COVID-19 and anosmia has been demonstrated worldwide. Calcium cations play an essential role in odor transmission, including feedback inhibition. Therefore, it is suggested that reducing intranasal free calcium cations with topical chelating agent pentasodium diethylenetriamine pentaacetate may improve olfactory function in patients with anosmia post COVID-19 infection. Design: Prospective controlled clinical trial to test use of pentasodium diethylenetriamine pentaacetate for post COVID-19 olfactory loss. Setting: ENT Department (Institution blinded for review). Participants: Sixty-six adult patients with history of confirmed COVID-19 and olfactory dysfunction persisted more than 90 days after SARS-CoV-2 negative testing were included. Main outcome measures: Participants were divided into 2 equal groups receiving nasal spray containing either 0.9% sodium chloride or 2% pentasodium diethylenetriamine pentaacetate. Olfactory function was assessed before treatment and 1 month later using the Sniffin’ Sticks test. A carbon paste ion-selective electrode was developed for quantitative analysis of calcium cation concentrations in nasal mucus before treatment and 1 month later. Results: After treatment with pentasodium diethylenetriamine pentaacetate, there was a significant improvement from functional anosmia to hyposmia compared with sodium chloride. In addition, the decrease of calcium concentration was recorded after treatment with pentasodium diethylenetriamine pentaacetate compared with sodium chloride. Conclusion: Based on the results of the proposed study, topical use of pentasodium diethylenetriamine pentaacetate may be a useful therapy for olfactory dysfunction after COVID-19.